Page last updated: 2024-10-24
chloroquine and Adenoma, Prolactin-Secreting, Pituitary
chloroquine has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 1 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Chloroquine (CQ) is an old drug widely used to treat malaria." | 1.46 | Pituitary Tumor Suppression by Combination of Cabergoline and Chloroquine. ( Cao, L; Guo, YH; Leng, ZG; Lin, SJ; Shang, HB; Wu, ZB; Wu, ZR; Zhang, X; Zhang, Y; Zhao, WG, 2017) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Lin, SJ | 1 |
| Wu, ZR | 1 |
| Cao, L | 1 |
| Zhang, Y | 1 |
| Leng, ZG | 1 |
| Guo, YH | 1 |
| Shang, HB | 1 |
| Zhao, WG | 1 |
| Zhang, X | 1 |
| Wu, ZB | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| The Effect of Combined Treatment of Cabergoline With Hydroxychloroquine/Chloroquine for Resistant Prolactinomas[NCT03400865] | | 30 participants (Anticipated) | Interventional | 2018-10-25 | Not yet recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for chloroquine and Adenoma, Prolactin-Secreting, Pituitary